Home ›
Trademark Categories ›
Pharmaceuticals ›
2011 ›
AL ›
ALREXIL
Trademark search for:
ALREXIL
No active United States Patent and Trademark Office (USPTO) registrations found, based on publicly available USPTO trademark records.
Trademark records may change over time.
For the most up-to-date trademark status, domain availability,
and social handle checks, run a live search.
Check latest trademark, domains & social handles
Live search · Most up-to-date results
USPTO Filing History
Key events recorded for this trademark application
2011-11-28 — Application filed
2011-12-29 — Sn assigned for sect 66a appl from ib
2011-12-30 — Application filed
2012-01-03 — Application filed
2012-03-12 — Final disposition recorded
2012-03-12 — Assigned to examiner
2012-03-13 — Office action issued
2012-03-14 — Office action issued
2012-03-14 — Office action issued
2012-03-30 — Office action issued
2012-06-18 — Paper received
2012-07-03 — Assigned to lie
2012-07-12 — Amendment from applicant entered
2012-07-12 — Correspondence received in law office
2012-07-21 — Examiners amendment -written
2012-07-21 — Approved for pub - principal register
2012-07-21 — Examiner's amendment entered
2012-07-23 — Examiners amendment mailed
2012-07-25 — Law office publication review completed
2012-08-08 — Notice of publication
2012-08-08 — Notification of possible opposition sent to ib
2012-08-08 — Notice of start of opposition period created, to be sent to ib
2012-08-28 — Published for opposition
2012-09-30 — Notification processed by ib
2012-11-13 — Registered-principal register
2013-02-13 — Final disposition recorded
2013-02-24 — Limitation of goods received from ib
2013-03-12 — Correction under section 7 - processed
2013-03-12 — Limitation from the ib examined and entered
2013-03-12 — Assigned to paralegal
2013-05-31 — New representative at ib received
2013-06-19 — Final disposition recorded
2013-06-19 — Final disposition recorded
2013-07-06 — Final disposition recorded
2013-11-12 — Partial invalidation of reg ext protection created
2014-06-10 — Invalidation reviewed - no action required by office
2015-12-18 — Limitation of goods received from ib
2016-03-20 — Correction under section 7 - processed
2016-03-21 — Limitation from the ib examined and entered
2016-12-01 — New representative at ib received
2019-05-07 — Attorney/dom.rep.revoked and/or appointed
2019-05-07 — Teas revoke/app/change addr of atty/dom rep received
2019-06-14 — Cancelled section 71
2020-02-14 — Total invalidation of reg ext protection created
2020-05-14 — Total invalidation of reg ext protection sent to ib
2020-05-14 — Invalidation processed
2020-06-12 — Total invalidation processed by the ib
2021-11-28 — Final status recorded
2022-06-26 — Death of international registration
2022-06-26 — Notification of effect of cancellation of intl reg e-mailed
Owner Information
Alnapharm GmbH & Co. KG
DE
Alnapharm GmbH & Co. KG
DE
Alnapharm GmbH & Co. KG
DE
Correspondent
Elizabeth A. Linford LADAS & PARRY LLP 4525 Wilshire Boulevard Suite 240 Los Angeles, CA 90010
Filing Details
Filing Date:
2011-11-28
Status Date:
2021-11-28
Disclaimer: This page is informational only and does not constitute legal advice.
Trademark availability depends on jurisdiction, usage, and legal interpretation.